Trial intelligence / Profile preview

Lanolin vs Breastmilk for Sore and Damaged Nipples

NCT04153513Phase 2Completed

Sponsor
University of Mostar
Start
Jan 2019
Primary completion
Sep 2020
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, randomised, open-label trial of lanolin in nipple pain and cracked nipple (2 arms), sponsored by University of Mostar. Primary endpoints: Nipple pain severity at 7 days and Nipple trauma score at 7 days. Started Jan 2019; status: completed.

02

Drugs

lanolin
03

Conditions

nipple paincracked nipple

Beyond the preview

Go deeper on NCT04153513.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04153513.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call